Advertisement

Functional Neurological Disorder and Dissociative Disorders in Women

  • Geoffrey RaynorEmail author
  • Gaston Baslet
Chapter

Abstract

This chapter provides a review of the epidemiology, phenomenology, pathophysiology, clinical evaluation, and treatment of functional neurological disorders (FND) and dissociative disorders, highlighting aspects that are specifically pertinent to women. There is also discussion about their overlap. Women outnumber men in FND, though evidence of sex-based prevalence differences in dissociative disorders is mixed. Both disorders share a lack of integration of specific neurological functions, often in the setting of a trauma history. Evidence-based treatment for both disorders is emerging, with no clear indication at this point that intervention effectiveness differs based on sex.

Keywords

Functional neurological disorder Dissociative disorder Conversion Hysteria Psychogenic seizures Dissociation Dissociative identity disorder Depersonalization Derealization Dissociative fugue And trauma-related disorders 

References

  1. 1.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.CrossRefGoogle Scholar
  2. 2.
    Trimble M, Reynolds EH. A brief history of hysteria: from the ancient to the modern. Hand Clin Neurol. 2016;139(Functional Neurological Disorders):3–10.CrossRefGoogle Scholar
  3. 3.
    Stone J, Sharpe M, Rothwell PM, Warlow CP. The12-year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry. 2003;74(5):591–6.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Duncan R, Graham CD, Oto M. Outcome at 5-10 years in psychogenic nonepileptic seizures: what patients report vs. what family doctors report. Epilepsy Behav. 2014;37:71–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Carson A, Lehn A. Epidemiology. Hand Clin Neurol. 2016;139(Functional Neurological Disorders):47–60.CrossRefGoogle Scholar
  6. 6.
    Stone J, Carson A, Duncan R, Roberts R, Warlow C, Coleman R, et al. Who is referred to neurology clinics? – the diagnoses made in 3781 new patients. Clin Neurol Neurosurg. 2010;112(9):747–51.PubMedCrossRefGoogle Scholar
  7. 7.
    Stone J, Carson A. An integrated approach to other functional neurological symptoms and related disorders. In: Dworetzky B, Baslet G, editors. Psychogenic nonepileptic seizures: towards the integration of care. New York: Oxford; 2017. p. 290–307.Google Scholar
  8. 8.
    Ladwig KH, Marten-Mittag B, Formanek B, Dammann G. Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol. 2000;16(6):511–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry. 2005;62(8):903–10.PubMedCrossRefGoogle Scholar
  10. 10.
    Stone J, Smyth R, Carson A, Lewis S, Prescott R, Warlow C, et al. Systematic review of misdiagnosis of conversion symptoms and “hysteria”. BMJ. 2005;331(7523):989.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Kotagal P, Costa M, Wyllie E, Wolgamuth B. Paroxysmal nonepileptic events in children and adolescents. Pediatrics. 2002;110(4):e46.PubMedCrossRefGoogle Scholar
  12. 12.
    Duncan R, Oto M, Martin E, Pelosi A. Late onset psychogenic nonepileptic attacks. Neurology. 2006;66(11):1644–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Stone J. Functional neurological disorders: the neurological assessment as treatment. Neurophysiol Clin. 2014;44(4):363–73.PubMedCrossRefGoogle Scholar
  14. 14.
    Morgante F, Edwards MJ, Espay AJ. Psychogenic movement disorders. Continuum (Minneap Minn). 2013;19(5 Movement Disorders):1383–96.Google Scholar
  15. 15.
    LaFrance WC, Baker GA, Duncan R, Goldstein LH, Reuber M. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach, a report from the international league against epilepsy nonepileptic seizures task force. Epilepsia. 2013;54(11):2005–18.PubMedCrossRefGoogle Scholar
  16. 16.
    Alving J. Serum prolactin levels are elevated also after pseudo-epileptic seizures. Seizure. 1998;7(2):85–9.PubMedGoogle Scholar
  17. 17.
    Chen DK, So YT, Fisher RS. Therapeutics and technology assessment subcommittee of the American Academy of Neurology. Use of serum prolactin in diagnosing epileptic seizures: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 2005;65(5):668–75.PubMedCrossRefGoogle Scholar
  18. 18.
    Matin N, Young SS, Williams B, LaFrance WC Jr, King JN, Caplan D, Chemali Z, Weilburg JB, Dickerson BC, Perez DL. Neuropsychiatric associations with gender, illness duration, work disability, and motor subtype in a U.S. functional neurological disorders clinic population. J Neuropsychiatry Clin Neurosci. 2017;29(4):375–82.PubMedCrossRefGoogle Scholar
  19. 19.
    Hopp JL, Anderson KE, Krumholz A, Gruber-Baldini AL, Shulman LM. Psychogenic seizures and psychogenic movement disorders: are they the same patients? Epilepsy Behav. 2012;25(4):666–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Driver-Dunckley E, Stonnington CM, Locke DE, Noe K. Comparison of psychogenic movement disorders and psychogenic nonepileptic seizures: is phenotype clinically important? Psychosomatics. 2011;52(4):337–45.PubMedCrossRefGoogle Scholar
  21. 21.
    van Merode T, de Krom MC, Knottnerus JA. Gender-related differences in non-epileptic attacks: a study of patients’ cases in the literature. Seizure. 1997;6(4):311–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Gale SD, Hill SW, Pearson C. Seizure semiology in males with psychogenic nonepileptic seizures is associated with somatic complaints. Epilepsy Res. 2015;115:153–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Say GN, Tasdemir HA, Ince H. Semiological and psychiatric characteristics of children with psychogenic nonepileptic seizures: gender-related differences. Seizure. 2015;31:144–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Asadi-Pooya AA, Emami M, Emami Y. Gender differences in manifestations of psychogenic non-epileptic seizures in Iran. J Neurol Sci. 2013;332(1–2):66–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Roelofs K, Pasman J. Stress, childhood trauma, and cognitive functions in functional neurologic disorders. Hand Clin Neurol. 2016;139(Functional Neurological Disorders):139–55.CrossRefGoogle Scholar
  26. 26.
    Oto M, Conway P, McGonigal A, Russell AJ, Duncan R. Gender differences in psychogenic non-epileptic seizures. Seizure. 2005;14(1):33–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Thomas AA, Preston J, Scott RC, Bujarski KA. Diagnosis of probable psychogenic nonepileptic seizures in the outpatient clinic: does gender matter? Epilepsy Behav. 2013;29(2):295–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Wang V, Salinsky M. Neurologic and medical factors. In: Dworetzky B, Baslet G, editors. Psychogenic nonepileptic seizures: towards the integration of care. New York: Oxford; 2017. p. 67–85.Google Scholar
  29. 29.
    Baslet G, Seshadri A, Bermeo-Ovalle A, Willment K, Myers L. Psychogenic non-epileptic seizures: an updated primer. Psychosomatics. 2016;57(1):1–17.PubMedCrossRefGoogle Scholar
  30. 30.
    Reuber M, Brown RJ. Understanding psychogenic nonepileptic seizures-phenomenology, semiology and the integrative cognitive model. Seizure. 2017;44:199–205.PubMedCrossRefGoogle Scholar
  31. 31.
    Edwards MJ. Neurobiologic theories of functional neurologic disorders. Hand Clin Neurol. 2016;139(Functional Neurological Disorders):131–7.CrossRefGoogle Scholar
  32. 32.
    Liepert J, Hassa T, Tuscher O. Electrophysiological correlates of motor conversion disorder. Mov Disord. 2008;23(15):2172–6.CrossRefGoogle Scholar
  33. 33.
    Bakvis P, Roelofs K, Kuyk J, Edelbroek PM, Swinkels WA, Spinhoven P. Trauma, stress, and preconscious threat processing in patients with psychogenic nonepileptic seizures. Epilepsia. 2009;50(5):1001–11.PubMedCrossRefGoogle Scholar
  34. 34.
    Reinsberger C, Sarkis R, Papadelis C, Doshi C, Perez DL, Baslet G, et al. Autonomic changes in psychogenic nonepileptic seizures: toward a potential diagnostic biomarker? Clin EEG Neurosci. 2015;46(1):16–25.PubMedCrossRefGoogle Scholar
  35. 35.
    Atmaca M, Aydin A, Tezcan E, Poyraz AK, Kara B. Volumetric investigation of brain regions in patients with conversion disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2006;30(4):708–13.CrossRefGoogle Scholar
  36. 36.
    Nicholson TR, Aybek S, Kempton MJ, Daly EM, Murphy DG, David AS, et al. A structural MRI study of motor conversion disorder: evidence of reduction in thalamic volume. J Neurol Neurosurg Psychiatry. 2014;85(2):227–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Aybek S, Nicholson TR, Draganski B, Daly E, Murphy DG, David AS, et al. Grey matter changes in motor conversion disorder. J Neurol Neurosurg Psychiatry. 2014;85(2):236–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Labate A, Cerasa A, Mula M, Mumoli L, Gioia MC, Aguglia U, et al. Neuroanatomic correlates of psychogenic nonepileptic seizures: a cortical thickness and VBM study. Epilepsia. 2012;53(2):377–85.PubMedCrossRefGoogle Scholar
  39. 39.
    Aybek S, Vuilleumier P. Imaging studies of functional neurologic disorders. Hand Clin Neurol. 2016;139(Functional Neurological Disorders):73–84.CrossRefGoogle Scholar
  40. 40.
    Voon V, Cavanna AE, Coburn K, Sampson S, Reeve A, LaFrance WC, et al. Functional neuroanatomy and neurophysiology of functional neurological disorders (conversion disorder). J Neuropsychiatry Clin Neurosci. 2016;28(3):168–90.PubMedCrossRefGoogle Scholar
  41. 41.
    Asadi-Pooya AA. Psychogenic nonepileptic seizures and sex differences in stress responses. Epilepsia. 2016;57(5):853.PubMedCrossRefGoogle Scholar
  42. 42.
    Hall-Patch L, Brown R, House A, Howlett S, Kemp S, Lawton G, et al. Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures. Epilepsia. 2010;51(1):70–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Razvi S, Mulhern S, Duncan R. Newly diagnosed psychogenic nonepileptic seizures: health care demand prior to and following diagnosis at a first seizure clinic. Epilepsy Behav. 2012;23(1):7–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Jirsch JD, Ahmed SN, Maximova K, Gross DW. Recognition of psychogenic nonepileptic seizures diminishes acute care utilization. Epilepsy Behav. 2011;22(2):304–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Ness D. Physical therapy management for conversion disorder: case series. J Neurol Phys Ther. 2007;31(1):30–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Nielsen G, Ricciardi L, Demartini B, Hunter R, Joyce E, Edwards MJ. Outcomes of a 5-day physiotherapy programme for functional (psychogenic) motor disorder. J Neurol. 2015;262(3):674–81.PubMedCrossRefGoogle Scholar
  47. 47.
    Jordbru AA, Smedstad LM, Klungsoyr O, Martinsen EW. Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. J Rehabil Med. 2014;46(2):181–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Voon V, Lang AE. Antidepressant treatment outcomes of psychogenic movement disorder. J Clin Psychiatry. 2005;66(12):1529–34.PubMedCrossRefGoogle Scholar
  49. 49.
    Pintor L, Baillus E, Matrai S, Carreno M, Donaire A, Boget T, et al. Efficiency of venlafaxine in patients with psychogenic nonepileptic seizures and anxiety and/or depressive disorders. J Neuropsychiatry Clin Neurosci. 2010;22(4):401–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ. Pharmacological interventions for somatoform disorders in adults. Cochrane Database Syst Rev. 2014;11:CD010628.Google Scholar
  51. 51.
    LaFrance WC Jr, Baird GL, Barry JJ, Blum AS, Frank Webb A, Keitner GI, Machan JT, Miller I, Szaflarski JP. NES treatment trial (NEST-T) consortium. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry. 2014;71(9):997–1005.PubMedCrossRefGoogle Scholar
  52. 52.
    Goldstein LH, Chalder T, Chigwedere C, Khondoker MR, Moriarty J, Toone BK, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures A pilot RCT. Neurology. 2010;74(24):1986–94.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Sharpe M, Walker J, Williams C, Stone J, Cavanagh J, Murray G, et al. Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology. 2011;77(6):564–72.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Williams C, Kent C, Smith S, Carson A, Sharpe M, Cavanagh J. Overcoming functional neurological symptoms: a five areas approach. London: Hodder Arnold; 2011.CrossRefGoogle Scholar
  55. 55.
    Reiter JM, Andrews D, Reiter C, LaFrance WC. Taking control of your seizures workbook. New York: Oxford University Press; 2015.CrossRefGoogle Scholar
  56. 56.
    Moene FC, Spinhoven P, Hoogduin KA, van Dyck R. A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychother Psychosom. 2002;71(2):66–76.PubMedCrossRefGoogle Scholar
  57. 57.
    Kompoliti K, Wilson B, Stebbins G, Bernard B, Hinson V. Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial. Parkinsonism Relat Disord. 2014;20(1):60–3.PubMedCrossRefGoogle Scholar
  58. 58.
    Mayor R, Howlett S, Grünewald R, Reuber M. Long-term outcome of brief augmented psychodynamic interpersonal therapy for psycho- genic nonepileptic seizures: seizure control and health care utilization. Epilepsia. 2010;51(7):1169–76.PubMedCrossRefGoogle Scholar
  59. 59.
    Barry JJ, Wittenberg D, Bullock KD, Michaels JB, Classen CC, Fisher RS. Group therapy for patients with psychogenic nonepileptic seizures: a pilot study. Epilepsy Behav. 2008;13(4):624–9.PubMedCrossRefGoogle Scholar
  60. 60.
    Myers L, Vaidya-Mathur U, Lancman M. Prolonged exposure therapy for the treatment of patients diagnosed with psychogenic non-epileptic seizures (PNES) and post-traumatic stress disorder (PTSD). Epilepsy Behav. 2017;66:86–92.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Baslet G, Dworetzky B, Perez DL, Oser M. Treatment of psychogenic nonepileptic seizures: updated review and findings from a mindfulness-based intervention case series. Clin EEG Neurosci. 2015;46(1):54–64.PubMedCrossRefGoogle Scholar
  62. 62.
    Kuyk J, Siffels MC, Bakvis P, Swinkels WA. Psychological treatment of patients with psychogenic non-epileptic seizures: an outcome study. Seizure. 2008;17(7):595–603.PubMedCrossRefGoogle Scholar
  63. 63.
    Zaroff CM, Myers L, Barr WB, Luciano D, Devinsky O. Group psycho-education as treatment for psychological nonepileptic seizures. Epilepsy Behav. 2004;5(4):587–92.PubMedCrossRefGoogle Scholar
  64. 64.
    Chastan N, Parain D. Psychogenic paralysis and recovery after motor cortex transcranial magnetic stimulation. Mov Disord. 2010;25(10):1501–4.PubMedCrossRefGoogle Scholar
  65. 65.
    Jaeger S, Steinert T, Uhlmann C, Flammer E, Bichescu-Burian D, Tschoke S. Dissociation in patients with borderline personality disorder in acute inpatient care – a latent profile analysis. Compr Psychiatry. 2017;78:67–75.PubMedCrossRefGoogle Scholar
  66. 66.
    Taylor MA, Viadya NA. Descriptive psychopathology; signs and symptoms of behavioral disorders. Cambridge, UK: Cambridge University Press; 2009.CrossRefGoogle Scholar
  67. 67.
    Steinberg M. The spectrum of depersonalization: assessment and treatment. In: Tasman A, Goldfinger SM, editors. American psychiatric press review of psychiatry, vol. 10. Washington, DC: American Psychiatric Press; 1991. p. 223–47.Google Scholar
  68. 68.
    Brand BL, Lanius R, Vermetten E, et al. Where are we going? An update an assessment, treatment, and neurobiological research in dissociative disorders as we move toward the DSM-5. J Trauma Dissociation. 2012;13(1):9–31.PubMedCrossRefGoogle Scholar
  69. 69.
    Kluft RP, editor. Childhood antecedents of multiple personality. Washington, DC: American Psychiatric Press; 1985.Google Scholar
  70. 70.
    Foote B, Smolin Y, Kaplan M, Legatt ME, Lipschitz D. Prevalence of dissociative disorders in psychiatric outpatients. Am J Psychiatr. 2006;163(4):623–9.PubMedCrossRefGoogle Scholar
  71. 71.
    Johnson JG, Cohen P, Kasen S, Brook JS. Dissociative disorders among adults in the community, impaired functioning, and axis I and II comorbidity. J Psychiatr Res. 2006;40(2):131–40.PubMedCrossRefGoogle Scholar
  72. 72.
    Lee WE, Kwok CHT, Hunter ECM, Richards M, David AS. Prevalence and childhood antecedents of depersonalization syndrome in a UK birth cohort. Soc Psychiatry Psychiatr Epidemiol. 2012;47(2):253–61.PubMedCrossRefGoogle Scholar
  73. 73.
    Hunter EC, Sierra M, David AS. The epidemiology of depersonalisation and derealisation: a systematic review. Soc Psychiatry Psychiatr Epidemiol. 2004;39(1):9–18.PubMedCrossRefGoogle Scholar
  74. 74.
    Stein DJ, Koenen KC, Friedman MJ, Hill E, McLaughlin KA, Petukhova M, et al. Dissociation in posttraumatic stress disorder: evidence from the world mental health surveys. Biol Psychiatry. 2013;73(4):302–12.PubMedCrossRefGoogle Scholar
  75. 75.
    Rodewald F, Wilhelm-Goling C, Emrich HM, Reddemann L, Gast U. Axis-I comorbidity in female patients with dissociative identity disorder and dissociative identity disorder not otherwise specified. J Nerv Ment Dis. 2011;199(2):122–31.PubMedCrossRefGoogle Scholar
  76. 76.
    Van Der Kloat D, Giesbrecht T, Franck E, Van Gastel A, De Volder I, Van Den Eede F, et al. Dissociative symptoms and sleep parameters – an all-night polysomnography study in patients with insomnia. Compr Psychiatry. 2013;54(6):658–64.CrossRefGoogle Scholar
  77. 77.
    Lyssenko L, Schmahl C, Bockhacker L, Vonderlin R, Bohus M, Kleindienst N. Dissociation in psychiatric sisorders: a meta-analysis of studies using the dissociative experiences scale. Am J Psychiatry. 2017;175:37–46.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Lambert MV, Sierra M, Phillips ML, David AS. The organic spectrum of depersonalization. A review plus four new cases. J Neuropsychiat Clin Neurosci. 2002;14:141–54.CrossRefGoogle Scholar
  79. 79.
    Allen JG, Smith WH. Diagnosing dissociative disorders. Bull Menn Clin. 1993;57(3):328–43.Google Scholar
  80. 80.
    Coons PM. The dissociative disorders: rarely considered and underdiagnosed. Psychiatr Clin N Am. 1998;21(3):637–64.CrossRefGoogle Scholar
  81. 81.
    Putnam FW. Dissociation in children and adolescents: a developmental perspective. New York: The Guilford Press; 1997.Google Scholar
  82. 82.
    Dalenberg CJ, Brand BL, Gleaves DH, et al. Evaluation of the evidence for the trauma and fantasy models of dissociation. Psychol Bull. 2012;138(3):550–88.PubMedCrossRefGoogle Scholar
  83. 83.
    Silberg J. The dissociative child. Lutherville: Sidran Press; 1996.Google Scholar
  84. 84.
    Giesbrecht T, Lynn SJ, Lilienfeld SO, Merckelbach H. Cognitive processes in dissociation: an analysis of core theoretical assumptions. Psychol Bull. 2008;134(5):617–47.PubMedCrossRefGoogle Scholar
  85. 85.
    Krause-Utz A, Frost R, Winter D, Elzinga BM. Dissociation and alterations in brain function and structure: implications for borderline personality disorder. Curr Psychiatry Rep. 2017;19(1):6.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Perez DL, Matin N, Williams B, Tanev K, Makris N, LaFrance WC, et al. Cortical thickness alterations linked to somatoform and psychological dissociation in functional neurological disorders. Hum Brain Mapp. 2018;39(1):428–39.PubMedCrossRefGoogle Scholar
  87. 87.
    Van Huijsteen J, Vermetten E. The dissociative subtype of post-traumatic stress disorder: research update on clinical and neurobiological features. Curr Top Behav Neurosci. 2017;38:229–48.CrossRefGoogle Scholar
  88. 88.
    Giesbrecht T, Jongen EM, Smulders FTY, Merckelbach H. Dissociation, resting EEG, and subjective sleep experiences in undergraduates. J Nerv Ment Dis. 2006;194(5):362–8.PubMedCrossRefGoogle Scholar
  89. 89.
    Okano K. Clinical handling of patients with dissociative disorders. Seishin Shinkeigaku Zasshi. 2015;117(6):399–412.PubMedGoogle Scholar
  90. 90.
    Myrick AC, Chasson GS, Lanius RA, Leventhal B, Brand BL. Treatment of complex dissociative disorders: a comparison of interventions reported by community therapists versus those recommended by experts. J Trauma Dissociation. 2015;16(1):51–67.PubMedCrossRefGoogle Scholar
  91. 91.
    Weiner E, McKay D. A preliminary evaluation of repeated exposure for depersonalization and derealization. Behav Modif. 2012;37(2):226–42.PubMedCrossRefGoogle Scholar
  92. 92.
    Brand BL, McNary SW, Myrick AC, Classen CC, Lanius R, Lowenstein RJ, et al. A longitudinal naturalistic study of patients with dissociative disorders treated by community clinicians. Psychol Trauma: Theory Res Pract Policy. 2012;5:301–8.CrossRefGoogle Scholar
  93. 93.
    Myrick AC, Webermann AR, Loewenstein RJ, Lanius R, Putnam FW, Brand BL. Six-year follow-up of the treatment of patients with dissociative disorders study. Eur J Psychotraumatol. 2017;8(1):1344080.PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Lilienfeld SO. Psychological treatments that cause harm. Perspect Psychol Sci. 2007;2(1):53–70.PubMedCrossRefGoogle Scholar
  95. 95.
    Gentile JP, Dillon KS, Gillig PM. Psychotherapy and pharmacotherapy for patients with dissociative identity disorder. Innov Clin Neurosci. 2013;10(2):22–9.PubMedPubMedCentralGoogle Scholar
  96. 96.
    Simeon D, Guralnik O, Schmeidler J, Knutelska M. Fluoxetine therapy in depersonalisation disorder: randomised controlled trial. Br J Psychiatry. 2004;185:31–6.PubMedCrossRefGoogle Scholar
  97. 97.
    Stern TA, Rosenbaum JF, Fava M, et al. Massachusetts general hospital comprehensive clinical psychiatry. Waltham: Elsevier Health Sciences; 2008.Google Scholar
  98. 98.
    Sierra M, Phillips ML, Ivin G, Krystal J, David AS. A placebo-controlled, cross-over trial of lamotrigine in depersonlization disorder. J Psychopharmacol. 2003;17(1):103–5.PubMedCrossRefGoogle Scholar
  99. 99.
    Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, Limberger MF, Böhme R, Schmahl CG. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial. J Clin Psychiatry. 1999;60:598–60.PubMedCrossRefGoogle Scholar
  100. 100.
    Schmahl C, Kleindienst N, Limberger M, Ludascher P, Mauchnik J, Deibler P, et al. Evaluation of naltrexone for dissociative symptoms in borderline personality disorder. Int Clin Psychopharmacol. 2012;27(1):61–8.PubMedCrossRefGoogle Scholar
  101. 101.
    Jay EL, Nestler S, Sierra M, McLelland J, Kekic M, David AS. Ventrolateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of depersonalization disorder: a consecutive case series. Psychiatry Res. 2016;240:118–22.PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Brown RJ, Cardena E, Nijenhuis E, Sar V, van der Hart O. Should conversion disorder be reclassified as a dissociative disorder in DSM V? Psychosomatics. 2007;48(5):369–78.PubMedCrossRefGoogle Scholar
  103. 103.
    Nijenhuis ER. Somatoform dissociation and somatoform dissociative disorders. In: Dell P, O’Neil J, editors. Dissociation and the dissociative disorders: DSM-V and beyond. New York: Routledge; 2009. p. 259–76.Google Scholar
  104. 104.
    World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.Google Scholar
  105. 105.
    Nijenhuis ER, Van Dyck R, Spinhoven P, van der Hart O, Chatrou M, Vanderlinden J, et al. Somatoform dissociation discriminates among diagnostic categories over and above general psychopathology. Aust N Z J Psychiatry. 1999;33(4):512–20.CrossRefGoogle Scholar
  106. 106.
    Nijenhuis ER, Van Dyck R, Ter Kuile MM, Moutitis MJE, Soinhoven P, van der Hart O. Evidence for associations among somatoform dissociation, psychological dissociation and reported trauma in patients with chronic pelvic pain. J Psychosom Obstet Gynecol. 2003;24(2):87–98.CrossRefGoogle Scholar
  107. 107.
    Sar V, Kundakci T, Kiziltan E, Bakim B, Bozkurt O. Differentiating dissociative disorders from other diagnostic groups through somatoform dissociation in Turkey. J Trauma Dissociation. 2000;1(4):67–80.CrossRefGoogle Scholar
  108. 108.
    Sar V, Akyüz G, Kundakçi T, Kiziltan E, Dogan O. Childhood trauma, dissociation, and psychiatric comorbidity in patients with conversion disorder. Am J Psychiatry. 2004;161(12):2271–6.PubMedCrossRefGoogle Scholar
  109. 109.
    Tezcan E, Atmaca M, Kuloglu M, Gecici O, Buyukbayram A, Tutkun H. Dissociative disorders in Turkish inpatients with conversion disorder. Compr Psychiatry. 2003;44(4):324–30.PubMedCrossRefGoogle Scholar
  110. 110.
    Spitzer C, Spelsberg B, Grabe HJ, Mundt B, Freyberger HJ. Dissociative experiences and psychopathology in conversion disorders. J Psychosom Res. 1999;46(3):291–4.PubMedCrossRefGoogle Scholar
  111. 111.
    Espirito-Santo H, Pio-Abreu JL. Psychiatric symptoms and dissociation in conversion, somatization and dissociative disorders. Aust N Z J Psychiatry. 2009;43(3):270–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of PsychiatryBrigham and Women’s HospitalBostonUSA
  2. 2.Harvard Medical SchoolBostonUSA

Personalised recommendations